aluates Reports

$ 0.0

Automative

Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2026

Published Date: 2026-03-06

Report Code: QYRE-Auto-34F2242

Global Onychomycosis Tinea Unguium Drug Market Insights and Forecast to 2027

BUY CHAPTERS

Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2026

Code: QYRE-Auto-34F2242

Report

2026-03-06

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Pfizer Inc

Valeant Pharma

Xiuzheng Pharmaceutical

Qilu Pharmaceutical

Yangtze River

Torrent Pharma

J & J

Chengdu Brilliant

Hubei Hengan

Taro

Perrigo

Galderma pharm

Zhejiang Deyer

Moberg

Onychomycosis (Tinea Unguium) Drug Market Size

The global Onychomycosis (Tinea Unguium) Drug market was valued at US$ 3869 million in 2025 and is anticipated to reach US$ 5710 million by 2032, at a CAGR of 5.8% from 2026 to 2032.

Onychomycosis (Tinea Unguium) Drug Market

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

Global Onychomycosis (Tinea Unguium) Drug key players include Pfizer, J&J, Novartis, Galderma pharm, Valeant Pharma, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 30%, followed by Europe and China both have a share over 45 percent.

In terms of product, Oral Medication is the largest segment, with a share over 70%. And in terms of application, the largest application is Age above 50, followed by Age under 18.

This report delivers a comprehensive overview of the global Onychomycosis (Tinea Unguium) Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Onychomycosis (Tinea Unguium) Drug. The Onychomycosis (Tinea Unguium) Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Onychomycosis (Tinea Unguium) Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Onychomycosis (Tinea Unguium) Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Onychomycosis (Tinea Unguium) Drug Market Report

Report Metric	Details
Report Name	Onychomycosis (Tinea Unguium) Drug Market
Accounted market size in 2025	US$ 3869 million
Forecasted market size in 2032	US$ 5710 million
CAGR	5.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Oral Medication External Medicine
Segment by Application	Age under 18 Age 18-50 Age above 50
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, Perrigo, Galderma pharm, Zhejiang Deyer, Valeant Pharma, Moberg
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Onychomycosis (Tinea Unguium) Drug companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Onychomycosis (Tinea Unguium) Drug Market growing?

Ans: The Onychomycosis (Tinea Unguium) Drug Market witnessing a CAGR of 5.8% during the forecast period 2026-2032.

What is the Onychomycosis (Tinea Unguium) Drug Market size in 2032?

Ans: The Onychomycosis (Tinea Unguium) Drug Market size in 2032 will be US$ 5710 million.

What is the market share of major companies in Onychomycosis (Tinea Unguium) Drug Market?

Ans: Global top five manufacturers hold a share about 35%.

What is the Onychomycosis (Tinea Unguium) Drug Market share by type?

Ans: In terms of product, Oral Medication is the largest segment, with a share over 70%.

Who are the main players in the Onychomycosis (Tinea Unguium) Drug Market report?

Ans: The main players in the Onychomycosis (Tinea Unguium) Drug Market are Pfizer, Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, Perrigo, Galderma pharm, Zhejiang Deyer, Valeant Pharma, Moberg

What are the Application segmentation covered in the Onychomycosis (Tinea Unguium) Drug Market report?

Ans: The Applications covered in the Onychomycosis (Tinea Unguium) Drug Market report are Age under 18, Age 18-50, Age above 50

What are the Type segmentation covered in the Onychomycosis (Tinea Unguium) Drug Market report?

Ans: The Types covered in the Onychomycosis (Tinea Unguium) Drug Market report are Oral Medication, External Medicine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral Medication

1.2.3 External Medicine

1.3 Market by Application

1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Age under 18

1.3.3 Age 18-50

1.3.4 Age above 50

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Onychomycosis (Tinea Unguium) Drug Market Perspective (2021–2032)

2.2 Global Onychomycosis (Tinea Unguium) Drug Growth Trends by Region

2.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Onychomycosis (Tinea Unguium) Drug Historic Market Size by Region (2021–2026)

2.2.3 Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Region (2027–2032)

2.3 Onychomycosis (Tinea Unguium) Drug Market Dynamics

2.3.1 Onychomycosis (Tinea Unguium) Drug Industry Trends

2.3.2 Onychomycosis (Tinea Unguium) Drug Market Drivers

2.3.3 Onychomycosis (Tinea Unguium) Drug Market Challenges

2.3.4 Onychomycosis (Tinea Unguium) Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Onychomycosis (Tinea Unguium) Drug Players by Revenue

3.1.1 Global Top Onychomycosis (Tinea Unguium) Drug Players by Revenue (2021–2026)

3.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Players (2021–2026)

3.2 Global Top Onychomycosis (Tinea Unguium) Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Onychomycosis (Tinea Unguium) Drug Revenue

3.4 Global Onychomycosis (Tinea Unguium) Drug Market Concentration Ratio

3.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis (Tinea Unguium) Drug Revenue in 2025

3.5 Global Key Players of Onychomycosis (Tinea Unguium) Drug Head Offices and Areas Served

3.6 Global Key Players of Onychomycosis (Tinea Unguium) Drug, Products and Applications

3.7 Global Key Players of Onychomycosis (Tinea Unguium) Drug, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Onychomycosis (Tinea Unguium) Drug Breakdown Data by Type

4.1 Global Onychomycosis (Tinea Unguium) Drug Historic Market Size by Type (2021–2026)

4.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Type (2027–2032)

5 Onychomycosis (Tinea Unguium) Drug Breakdown Data by Application

5.1 Global Onychomycosis (Tinea Unguium) Drug Historic Market Size by Application (2021–2026)

5.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size (2021–2032)

6.2 North America Onychomycosis (Tinea Unguium) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021–2026)

6.4 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size (2021–2032)

7.2 Europe Onychomycosis (Tinea Unguium) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021–2026)

7.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size (2021–2032)

8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2021–2026)

8.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size (2021–2032)

9.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021–2026)

9.4 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size (2021–2032)

10.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021–2026)

10.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Introduction

11.1.4 Pfizer Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.1.5 Pfizer Recent Development

11.2 Yangtze River

11.2.1 Yangtze River Company Details

11.2.2 Yangtze River Business Overview

11.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Introduction

11.2.4 Yangtze River Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.2.5 Yangtze River Recent Development

11.3 Torrent Pharma

11.3.1 Torrent Pharma Company Details

11.3.2 Torrent Pharma Business Overview

11.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Introduction

11.3.4 Torrent Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.3.5 Torrent Pharma Recent Development

11.4 J&J

11.4.1 J&J Company Details

11.4.2 J&J Business Overview

11.4.3 J&J Onychomycosis (Tinea Unguium) Drug Introduction

11.4.4 J&J Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.4.5 J&J Recent Development

11.5 Chengdu Brilliant

11.5.1 Chengdu Brilliant Company Details

11.5.2 Chengdu Brilliant Business Overview

11.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Introduction

11.5.4 Chengdu Brilliant Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.5.5 Chengdu Brilliant Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Introduction

11.6.4 Novartis Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.6.5 Novartis Recent Development

11.7 Qilu Pharmaceutical

11.7.1 Qilu Pharmaceutical Company Details

11.7.2 Qilu Pharmaceutical Business Overview

11.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Introduction

11.7.4 Qilu Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.7.5 Qilu Pharmaceutical Recent Development

11.8 Xiuzheng Pharmaceutical

11.8.1 Xiuzheng Pharmaceutical Company Details

11.8.2 Xiuzheng Pharmaceutical Business Overview

11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Introduction

11.8.4 Xiuzheng Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.8.5 Xiuzheng Pharmaceutical Recent Development

11.9 Hubei Hengan

11.9.1 Hubei Hengan Company Details

11.9.2 Hubei Hengan Business Overview

11.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Introduction

11.9.4 Hubei Hengan Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.9.5 Hubei Hengan Recent Development

11.10 TARO

11.10.1 TARO Company Details

11.10.2 TARO Business Overview

11.10.3 TARO Onychomycosis (Tinea Unguium) Drug Introduction

11.10.4 TARO Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.10.5 TARO Recent Development

11.11 Perrigo

11.11.1 Perrigo Company Details

11.11.2 Perrigo Business Overview

11.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Introduction

11.11.4 Perrigo Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.11.5 Perrigo Recent Development

11.12 Galderma pharm

11.12.1 Galderma pharm Company Details

11.12.2 Galderma pharm Business Overview

11.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Introduction

11.12.4 Galderma pharm Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.12.5 Galderma pharm Recent Development

11.13 Zhejiang Deyer

11.13.1 Zhejiang Deyer Company Details

11.13.2 Zhejiang Deyer Business Overview

11.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Introduction

11.13.4 Zhejiang Deyer Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.13.5 Zhejiang Deyer Recent Development

11.14 Valeant Pharma

11.14.1 Valeant Pharma Company Details

11.14.2 Valeant Pharma Business Overview

11.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Introduction

11.14.4 Valeant Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.14.5 Valeant Pharma Recent Development

11.15 Moberg

11.15.1 Moberg Company Details

11.15.2 Moberg Business Overview

11.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Introduction

11.15.4 Moberg Revenue in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

11.15.5 Moberg Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Pfizer Inc

Valeant Pharma

Xiuzheng Pharmaceutical

Qilu Pharmaceutical

Yangtze River

Torrent Pharma

J & J

Chengdu Brilliant

Hubei Hengan

Taro

Perrigo

Galderma pharm

Zhejiang Deyer

Moberg

List of Tables

Table 1. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral Medication

Table 3. Key Players of External Medicine

Table 4. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (US$ Million), 2021–2026

Table 7. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2021–2026)

Table 8. Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2027–2032)

Table 10. Onychomycosis (Tinea Unguium) Drug Market Trends

Table 11. Onychomycosis (Tinea Unguium) Drug Market Drivers

Table 12. Onychomycosis (Tinea Unguium) Drug Market Challenges

Table 13. Onychomycosis (Tinea Unguium) Drug Market Restraints

Table 14. Global Onychomycosis (Tinea Unguium) Drug Revenue by Players (US$ Million), 2021–2026

Table 15. Global Onychomycosis (Tinea Unguium) Drug Market Share by Players (2021–2026)

Table 16. Global Top Onychomycosis (Tinea Unguium) Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Onychomycosis (Tinea Unguium) Drug Revenue, 2025

Table 17. Ranking of Global Top Onychomycosis (Tinea Unguium) Drug Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Onychomycosis (Tinea Unguium) Drug Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Onychomycosis (Tinea Unguium) Drug, Headquarters and Area Served

Table 20. Global Key Players of Onychomycosis (Tinea Unguium) Drug, Products and Applications

Table 21. Global Key Players of Onychomycosis (Tinea Unguium) Drug, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (US$ Million), 2021–2026

Table 24. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2021–2026)

Table 25. Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2027–2032)

Table 27. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (US$ Million), 2021–2026

Table 28. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2021–2026)

Table 29. Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2027–2032)

Table 31. North America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2021–2026

Table 33. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (US$ Million), 2027–2032

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Onychomycosis (Tinea Unguium) Drug Product

Table 49. Pfizer Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 50. Pfizer Recent Development

Table 51. Yangtze River Company Details

Table 52. Yangtze River Business Overview

Table 53. Yangtze River Onychomycosis (Tinea Unguium) Drug Product

Table 54. Yangtze River Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 55. Yangtze River Recent Development

Table 56. Torrent Pharma Company Details

Table 57. Torrent Pharma Business Overview

Table 58. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product

Table 59. Torrent Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 60. Torrent Pharma Recent Development

Table 61. J&J Company Details

Table 62. J&J Business Overview

Table 63. J&J Onychomycosis (Tinea Unguium) Drug Product

Table 64. J&J Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 65. J&J Recent Development

Table 66. Chengdu Brilliant Company Details

Table 67. Chengdu Brilliant Business Overview

Table 68. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product

Table 69. Chengdu Brilliant Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 70. Chengdu Brilliant Recent Development

Table 71. Novartis Company Details

Table 72. Novartis Business Overview

Table 73. Novartis Onychomycosis (Tinea Unguium) Drug Product

Table 74. Novartis Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 75. Novartis Recent Development

Table 76. Qilu Pharmaceutical Company Details

Table 77. Qilu Pharmaceutical Business Overview

Table 78. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product

Table 79. Qilu Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 80. Qilu Pharmaceutical Recent Development

Table 81. Xiuzheng Pharmaceutical Company Details

Table 82. Xiuzheng Pharmaceutical Business Overview

Table 83. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product

Table 84. Xiuzheng Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 85. Xiuzheng Pharmaceutical Recent Development

Table 86. Hubei Hengan Company Details

Table 87. Hubei Hengan Business Overview

Table 88. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product

Table 89. Hubei Hengan Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 90. Hubei Hengan Recent Development

Table 91. TARO Company Details

Table 92. TARO Business Overview

Table 93. TARO Onychomycosis (Tinea Unguium) Drug Product

Table 94. TARO Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 95. TARO Recent Development

Table 96. Perrigo Company Details

Table 97. Perrigo Business Overview

Table 98. Perrigo Onychomycosis (Tinea Unguium) Drug Product

Table 99. Perrigo Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 100. Perrigo Recent Development

Table 101. Galderma pharm Company Details

Table 102. Galderma pharm Business Overview

Table 103. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product

Table 104. Galderma pharm Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 105. Galderma pharm Recent Development

Table 106. Zhejiang Deyer Company Details

Table 107. Zhejiang Deyer Business Overview

Table 108. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product

Table 109. Zhejiang Deyer Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 110. Zhejiang Deyer Recent Development

Table 111. Valeant Pharma Company Details

Table 112. Valeant Pharma Business Overview

Table 113. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product

Table 114. Valeant Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 115. Valeant Pharma Recent Development

Table 116. Moberg Company Details

Table 117. Moberg Business Overview

Table 118. Moberg Onychomycosis (Tinea Unguium) Drug Product

Table 119. Moberg Revenue in Onychomycosis (Tinea Unguium) Drug Business (US$ Million), 2021–2026

Table 120. Moberg Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Onychomycosis (Tinea Unguium) Drug Picture

Figure 2. Global Onychomycosis (Tinea Unguium) Drug Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type: 2025 vs 2032

Figure 4. Oral Medication Features

Figure 5. External Medicine Features

Figure 6. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application: 2025 vs 2032

Figure 8. Age under 18 Case Studies

Figure 9. Age 18-50 Case Studies

Figure 10. Age above 50 Case Studies

Figure 11. Onychomycosis (Tinea Unguium) Drug Report Years Considered

Figure 12. Global Onychomycosis (Tinea Unguium) Drug Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Onychomycosis (Tinea Unguium) Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region: 2025 vs 2032

Figure 15. Global Onychomycosis (Tinea Unguium) Drug Market Share by Players in 2025

Figure 16. Global Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2025

Figure 18. North America Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021–2032)

Figure 20. United States Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021–2032)

Figure 24. Germany Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share by Region (2021–2032)

Figure 32. China Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021–2032)

Figure 40. Mexico Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021–2032)

Figure 44. Israel Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Pfizer Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 48. Yangtze River Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 49. Torrent Pharma Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 50. J&J Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 51. Chengdu Brilliant Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 52. Novartis Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 53. Qilu Pharmaceutical Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 54. Xiuzheng Pharmaceutical Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 55. Hubei Hengan Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 56. TARO Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 57. Perrigo Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 58. Galderma pharm Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 59. Zhejiang Deyer Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 60. Valeant Pharma Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 61. Moberg Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Onychomycosis Treatment Market Research Report 2024

Global Fungal Drugs for Treatment of Tinea Market Research Report 2025

Global Dermatophytic Onychomycosis Therapeutics DOT Market Research Report 2024

Drugs for Dermatophytosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dermatophytosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dermatophytosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tinea Corporis Drugs Market Research Report 2024

Dermatophytosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fungal Nail Infections Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tinea Corporis Treatment Market Research Report 2025

Treatmet of Dermatophytosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Tinea Pedis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ringworm Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Dermatomycosis Treatment Market Research Report 2025

Global Fungal Foot Drugs Market Insights Forecast to 2030

Global Onychomycosis Therapy Market Research Report 2024

Global Antifungal Drugs for Skin Market Research Report 2024

Global Anti fungal Drugs Market Insights Forecast to 2030

Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions